Klk Capital Management LLC Incyte Corp Transaction History
Klk Capital Management LLC
- $75.7 Million
- Q3 2023
Shares
3 transactions
Others Institutions Holding INCY
# of Institutions
618Shares Held
215MCall Options Held
366KPut Options Held
445K-
Baker Bros. Advisors LP New York, NY36.2MShares$2.07 Billion26.1% of portfolio
-
Black Rock Inc. New York, NY23.2MShares$1.33 Billion0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA22.7MShares$1.3 Billion0.03% of portfolio
-
Dodge & Cox San Francisco, CA15.4MShares$884 Million0.54% of portfolio
-
State Street Corp Boston, MA9.9MShares$568 Million0.03% of portfolio
About INCYTE CORP
- Ticker INCY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 222,431,008
- Market Cap $12.8B
- Description
- Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...